» Articles » PMID: 38792632

Cytotoxic Activity of the Red Grape Polyphenol Resveratrol Against Human Prostate Cancer Cells: A Molecular Mechanism Mediated by Mobilization of Nuclear Copper and Generation of Reactive Oxygen Species

Overview
Journal Life (Basel)
Specialty Biology
Date 2024 May 25
PMID 38792632
Authors
Affiliations
Soon will be listed here.
Abstract

Resveratrol, a polyphenolic compound found primarily in red grapes and pomegranates is known as an antioxidant but can act as a pro-oxidant when copper ions are present. Here, resveratrol is demonstrated to reduce cell growth (as evaluated by MTT assay) and promote apoptosis-like cell death (as measured by Histone/DNA ELISA) in prostate cancer cell lines PC3 and C42B. This effect is effectively inhibited by a copper chelator (neocuproine) and reactive oxygen species (ROS) scavengers (thiourea for hydroxyl radical, superoxide dismutase for superoxide anion, and catalase for hydrogen peroxide). These inhibitory effects provide evidence that intracellular copper reacts with resveratrol within cancer cells, resulting in DNA damage via the generation of reactive oxygen species. Additionally, it has been demonstrated that non-tumorigenic epithelial cell lines (MCF-10A) grown in media supplemented with copper are more susceptible to growth inhibition by resveratrol, as confirmed by the observed reduction in cell proliferation. Copper supplementation induces enhanced expression of the copper transporter in MCF-10A cells, which is reduced by the addition of resveratrol to the media. The selective cell death of cancer cells generated by copper-mediated and ROS mechanisms may help to explain the anticancer properties of resveratrol.

References
1.
Andrade S, Ramalho M, Pereira M, Loureiro J . Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment. Front Pharmacol. 2018; 9:1261. PMC: 6262174. DOI: 10.3389/fphar.2018.01261. View

2.
Farhan M, Rizvi A . The Pharmacological Properties of Red Grape Polyphenol Resveratrol: Clinical Trials and Obstacles in Drug Development. Nutrients. 2023; 15(20). PMC: 10610408. DOI: 10.3390/nu15204486. View

3.
Frankel E, Waterhouse A, Kinsella J . Inhibition of human LDL oxidation by resveratrol. Lancet. 1993; 341(8852):1103-4. DOI: 10.1016/0140-6736(93)92472-6. View

4.
Kjaer T, Ornstrup M, Poulsen M, Jorgensen J, Hougaard D, Cohen A . Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men. Prostate. 2015; 75(12):1255-63. DOI: 10.1002/pros.23006. View

5.
Paller C, Rudek M, Zhou X, Wagner W, Hudson T, Anders N . A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination. Prostate. 2015; 75(14):1518-25. PMC: 4537354. DOI: 10.1002/pros.23024. View